Upgrade to SI Premium - Free Trial

Seattle Genetics (SGEN) PT Raised to $79 at Needham & Company

July 27, 2018 12:22 PM
Needham & Company raised its price target on Seattle Genetics (NASDAQ: SGEN) to $79.00 (from $74.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles